维普中文期刊产品整合服务
14篇 您的检索式:作者名="MAIELLO M R"
    题名 作者 年代 出处 被引量
1一种miRNA标记在胶质瘤侵袭性表型的确定与预后评估中的价值(英文)显示文摘Gliomas represent a disparate group of tumours for which there are to date no cure. Thus,there is a recognized need for new diagnostic and therapeutic approaches based on increased understanding of their molecular nature. We performed the comparison of the microRNA( miRNA) profile of 8 WHO grade II gliomas and 24 higher grade tumours( 2 WHO grade III and 22 glioblastomas) by using the Affymetrix Gene Chip miRNA Array v. 1. 0. A relative quantification method( RT-q PCR) with standard curve was used to confirm the 22 miRNA signature resulted by array analysis. The prognostic performances of the confirmed miRNAs were estimated on the Tumor Cancer Genome Atlas( TCGA) datasets. We identified 22 miRNAs distinguishing grade II gliomas from higher grade tumours.RT-q PCR confirmed the differential expression in the two patients' groups for 13 out of the 22 miRNAs. The analysis of the Glioblastoma Multiforme( GBM) and Lower Grade Glioma( LGG) datasets from TCGA demonstrated the association with prognosis for 6 of those miRNAs. Moreover,in the GBM dataset miR-21 and miR-210 were predictors of worse prognosis in both univariable and multivariable Cox regression analyses( HR 1. 19,P = 0. 04,and HR 1. 18,P = 0. 029 respectively). Our results support a direct contribution of miRNAs to glioma cancerogenesis and suggest that miR-21 and miR-210 may play a role in the aggressive clinical behaviour of glioblastomas.Barbano R Palumbo O Pasculli B Galasso M Volinia S D'Angelo V Icolaro N Coco M Dimitri L Graziano P Copetti M Valori VM Maiello E Carella M Fazio VM Parrella P 2014中华神经外科疾病研究杂志2014,13,5:6
2EGFR and MEK blockade in tri- ple negative breast cancer ceils 显示文摘MAIELLO M R D'ALESSIO A 2015J Cell Biochem2015,116,12:1
3Evaluation of cytotoxic concentration-time response in A549 cells exposed to respirable α-quartz显示文摘FANIZZA C FRESEGNA A M MAIELLO R 2009J Appl Toxicol2009,29,:1
4Fetal lung lesions diagnosis:the crucial role of ultrasonography显示文摘Pedata R Palermo M Maiello M 2009J Prenat Med2009,3,4:1
5Epidermal growth factor receptor tyrosine kinase inhibitors (EG- FR-TKIs) : simple drugs with a complex mechanism of action显示文摘Normanno N Maiello M R De Luca A 2003J''Cell Physiol2003,194,:1
6The RAS/RAF/MEK/ ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches 显示文摘De Luca A Maiello M R D'Alessio A 2012Expert Opin Ther Targets2012,16,:1
7Fetal lung lesions diagnosis:the crucial role of ultrasonography显示文摘Pedata R Palermo M Maiello M 0,,4:1
8The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib显示文摘NORMANNO N DE LUCA A MAIELLO M R 2006J Cell Physiol2006,207,2:1
9Breast cancer ceils with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signal 显示文摘NORMANNO N CAMPIGLIO M MAIELLO M R 2008Breast Cancer Res Treat2008,112,1:1
10Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling 显示文摘NORMANNO N CAMPIGLIO M MAIELLO M R 2008Breast Cancer Res Treat2008,112,1:1
11The MEK/ MAPK pathway is involved in the resistance of breast cancer ceils to the EGFR tyrosine kinase inhibitor gefitinib显示文摘NORMANNO N DE LUCA A MAIELLO M R 2006J Cell Physiol2006,207,2:1
12The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways:role in cancer pathogenesis and implications for therapeutic approaches显示文摘De Luca A Maiello M R D'Alessio A 2012Expert Opin Ther Targets2012,16,2:1
13The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways:role in Cancer patho-genesis and implications for therapeutic approaches显示文摘De Luca A Maiello M R D'alessio A 2012Expert Opin Ther Targets2012,16,2:1
14The RAS/RAF/ MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches 显示文摘De Luca A Maiello M R D'Alessio A 2012Ex- pert Opin Ther Targets2012,2,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费